It can take years for prostate cancer to turn castration-resistant, when cancer cells stop responding to hormonal therapy.

Metastatic means the cancer has spread from the prostate to other parts of the body, like the bones, liver, or lungs. This makes the disease harder to treat since it's no longer just in one place.

Metastatic castration-resistant prostate cancer (mCRPC) is diagnosed by blood tests, imaging scans, and biopsies. Find out ...

Two phase 3 trials of Merck & Co's Keytruda in metastatic castration-resistant prostate cancer (CRPC) and advanced liver cancer have ended in failure, proving once again that cancer immunotherapy ...

Pilatus Biosciences, a biotechnology company developing immunometabolic therapies for cancer, today announced a preclinical publication in Cancer Discovery detailing the mechanism and therapeutic ...

The pre-analytical workflow is one of the primary considerations in the successful use of liquid biopsies for cancer ...

There is no standard of care for fibrolamellar liver cancer, no targeted therapies. But that may be changing, thanks to ...

Linda Nolan's stepson, who was suffering from metastatic throat cancer, has sadly died four months after the singer passed ...

Nauseef JT, Sun MP, Thomas C, et al. A phase I/II dose-escalation study of fractionated 225Ac-J591 for progressive metastatic castration-resistant prostate cancer in patients with prior treatment with ...